Canadian journal of public health = Revue canadienne de sante publique · 2026
Non-medical opioid (NMO) use in Canadian adolescents: Trends, risk factors, and regional variations.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Singh Samarpreet, Borkenhagen David, Mushquash Christopher, Dimitropoulos Gina, Arnold Paul
Аннотация
INTRODUCTION: Non-medical opioid (NMO) use is a serious issue among Canadian adolescents. Previous research has mainly focused on increases in opioid disorders and opioid-related mortality, while a focus on NMO use has been limited. Therefore, this study aims to examine how the reported NMO use changed over time among Canadian adolescents, focusing on three types of opioids: oxycodone, fentanyl, and other opioids (such as morphine, codeine, Tylenol #3). Additionally, this study will investigate demographic correlates of reported NMO use, including province of residence, age, Indigenous identity, sex, and urban/rural location.
METHODS: Canadian Student Tobacco, Alcohol, and Drugs Survey data (2014-2015, 2016-2017, 2018-2019, and 2021-2022) were used. Adjusted logistic regression analyses, accounting for changes in respondent demographics, were conducted.
RESULTS: Overall adolescent reported past 12-month NMO use increased (2.5-3.2%) between 2014-2015 and 2021-2022. Specifically, past 12-month non-medical use of oxycodone (1.0-1.4%) and fentanyl (0.4-0.9%) increased over the study period, while use of other opioids declined slightly by 0.2% between 2018-2019 and 2021-2022. However, adjusted logistic regression analyses indicated that the odds of oxycodone use decreased between 2018-2019 and 2021-2022 (AOR = 0.88; 95% CI 0.86-0.90), whereas fentanyl use showed no significant change (AOR = 1.01; 95% CI 0.99-1.04). High school students, Indigenous-identifying, rural adolescents, and those in Alberta, Manitoba, and Quebec were particularly at higher odds.
CONCLUSION: These findings call for continued efforts to regulate and prevent NMO use, especially among adolescents who are more likely to engage in such behaviours.
METHODS: Canadian Student Tobacco, Alcohol, and Drugs Survey data (2014-2015, 2016-2017, 2018-2019, and 2021-2022) were used. Adjusted logistic regression analyses, accounting for changes in respondent demographics, were conducted.
RESULTS: Overall adolescent reported past 12-month NMO use increased (2.5-3.2%) between 2014-2015 and 2021-2022. Specifically, past 12-month non-medical use of oxycodone (1.0-1.4%) and fentanyl (0.4-0.9%) increased over the study period, while use of other opioids declined slightly by 0.2% between 2018-2019 and 2021-2022. However, adjusted logistic regression analyses indicated that the odds of oxycodone use decreased between 2018-2019 and 2021-2022 (AOR = 0.88; 95% CI 0.86-0.90), whereas fentanyl use showed no significant change (AOR = 1.01; 95% CI 0.99-1.04). High school students, Indigenous-identifying, rural adolescents, and those in Alberta, Manitoba, and Quebec were particularly at higher odds.
CONCLUSION: These findings call for continued efforts to regulate and prevent NMO use, especially among adolescents who are more likely to engage in such behaviours.